Back to Search
Start Over
alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
- Source :
- British Journal of Pharmacology; Jul2008, Vol. 154 Issue 6, p1287-1296, 10p, 1 Diagram, 4 Graphs
- Publication Year :
- 2008
-
Abstract
- Background and purpose:The imidazoline-type α<subscript>2</subscript>-adrenoceptor antagonists (±)-efaroxan and phentolamine increase insulin secretion and reduce blood glucose levels. It is not known whether they act by antagonizing pancreatic β-cell α<subscript>2</subscript>-adrenoceptors or by α<subscript>2</subscript>-adrenoceptor-independent mechanisms. Many imidazolines inhibit the pancreatic β-cell K<subscript>ATP</subscript> channel, which is the molecular target of sulphonylurea drugs used in the treatment of type II diabetes. To investigate the mechanisms of action of (±)-efaroxan and phentolamine, α<subscript>2A</subscript>-adrenoceptor knockout (α<subscript>2A</subscript>-KO) mice were used.Experimental approach:Effects of (±)-efaroxan, 5 mg kg<superscript>−1</superscript>, and phentolamine, 1 mg kg<superscript>−1</superscript>, on blood glucose and insulin levels were compared with those of the non-imidazoline α<subscript>2</subscript>-adrenoceptor antagonist [8aR,12aS,13aS]-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-methoxy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6]naphthyridine (RS79948-197), 1 mg kg<superscript>−1</superscript>, and the sulphonylurea glibenclamide, in α<subscript>2A</subscript>-KO and control (wild type (WT)) mice.Key results:In fed WT mice, (±)-efaroxan, phentolamine and RS79948-197 reduced blood glucose and increased insulin levels. Fasting abolished these effects. In fed α<subscript>2A</subscript>-KO mice, (±)-efaroxan, phentolamine and RS79948-197 did not alter blood glucose or insulin levels, and in fasted α<subscript>2A</subscript>-KO mice, blood glucose levels were increased. Glibenclamide, at a dose only moderately efficacious in WT mice (5 mg kg<superscript>−1</superscript>), caused severe hyperinsulinaemia and hypoglycaemia in α<subscript>2A</subscript>-KO mice. This was mimicked in WT mice by co-administration of RS79948-197 with glibenclamide.Conclusions and implications:These results suggest that (±)-efaroxan and phentolamine increase insulin secretion by inhibition of β-cell α<subscript>2A</subscript>-adrenoceptors, and demonstrate a critical role for α<subscript>2A</subscript>-adrenoceptors in limiting sulphonylurea-induced hyperinsulinaemia and hypoglycaemia.British Journal of Pharmacology (2008) 154, 1287–1296; doi:10.1038/bjp.2008.186; published online 19 May 2008 [ABSTRACT FROM AUTHOR]
- Subjects :
- INSULIN
MICE
GLIBENCLAMIDE
ADRENERGIC receptors
IMIDAZOLINES
HYPOGLYCEMIA
ADRENERGIC alpha blockers
FASTING
RESEARCH
HYPOGLYCEMIC sulfonylureas
PROPRANOLOL
HETEROCYCLIC compounds
ANIMAL experimentation
ATROPINE
RESEARCH methodology
HYPOGLYCEMIC agents
ISOQUINOLINE
CELL receptors
BLOOD sugar
MEDICAL cooperation
EVALUATION research
IMIDAZOLES
ADRENERGIC beta blockers
COMPARATIVE studies
DRUG synergism
PHENTOLAMINE
MUSCARINIC antagonists
PHARMACODYNAMICS
Subjects
Details
- Language :
- English
- ISSN :
- 00071188
- Volume :
- 154
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- British Journal of Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 33137973
- Full Text :
- https://doi.org/10.1038/bjp.2008.186